BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hao XW, Zhu ST, He YL, Li P, Wang YJ, Zhang ST. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma. World J Gastroenterol 2012; 18(6): 532-540 [PMID: 22363119 DOI: 10.3748/wjg.v18.i6.532]
URL: https://www.wjgnet.com/1007-9327/full/v18/i6/532.htm
Number Citing Articles
1
Li Shang, Mingrong Wang. Molecular alterations and clinical relevance in esophageal squamous cell carcinomaFrontiers of Medicine 2013; 7(4): 401 doi: 10.1007/s11684-013-0286-y
2
The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene PromoterTechnology in Cancer Research & Treatment 2019; 18: 153303381987797 doi: 10.1177/1533033819877977
3
Hongxiao Wang, Zijun Song, Enjun Xie, Junyi Chen, Biyao Tang, Fudi Wang, Junxia Min. Targeting the LSD1-G9a-ER Stress Pathway as a Novel Therapeutic Strategy for Esophageal Squamous Cell CarcinomaResearch 2022; 2022 doi: 10.34133/2022/9814652
4
Raghibul Hasan, Gunjan Srivastava, Akram Alyass, Rinu Sharma, Anoop Saraya, Tushar K. Chattopadhyay, Siddartha DattaGupta, Paul G. Walfish, Shyam S. Chauhan, Ranju Ralhan. Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk modelOncotarget 2022; 13(1): 1020 doi: 10.18632/oncotarget.10656
5
Xiao‐Song Ge, Hua‐Juan Ma, Xiao‐Hui Zheng, Hong‐Lian Ruan, Xiao‐Yu Liao, Wen‐Qiong Xue, Yuan‐Bin Chen, Ying Zhang, Wei‐Hua Jia. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF‐1 expression and activates Wnt pathwayCancer Science 2013; 104(12): 1675 doi: 10.1111/cas.12296
6
Yasushi Toh, Akinori Egashira, Manabu Yamamoto, Shohei Yamaguchi. Interplay among epigenetic alterations and crosstalk between genetic and epigenetic alterations in esophageal squamous cell carcinomaEsophagus 2014; 11(3): 162 doi: 10.1007/s10388-014-0431-y
7
Jun Yu, Yang Xie, Mengying Li, Fenfang Zhou, Zhenyang Zhong, Yuting Liu, Feng Wang, Jian Qi. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta‑analysisOncology Letters 2019;  doi: 10.3892/ol.2019.10709
8
Vanessa Ortiz-Barahona, Ricky S. Joshi, Manel Esteller. Use of DNA methylation profiling in translational oncologySeminars in Cancer Biology 2022; 83: 523 doi: 10.1016/j.semcancer.2020.12.011
9
Long Liao, Zi‐Ting Yao, Wang‐Kai Fang, Qing‐Yu He, Wen Wen Xu, Bin Li. Epigenetics in Esophageal Cancer: From Mechanisms to TherapeuticsSmall Methods 2020; 4(10) doi: 10.1002/smtd.202000391
10
Pere Llinàs-Arias, Manel Esteller. Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an updateOpen Biology 2017; 7(9): 170152 doi: 10.1098/rsob.170152
11
Fatemeh Ardalan Moghadam Al, Mohammad Mahdi Forghanifard, Vajiheh Zarrinpour. PYGO2 increases proliferation and migration capacities through critical signaling pathways in esophageal squamous cell carcinomaJournal of Biochemical and Molecular Toxicology 2024; 38(1) doi: 10.1002/jbt.23625
12
Yu Lian, Xiangdong Niu, Hui Cai, Xiaojun Yang, Haizhong Ma, Shixun Ma, Yupeng Zhang, Yifeng Chen. Clinicopathological significance of c-MYC in esophageal squamous cell carcinomaTumor Biology 2017; 39(7): 101042831771580 doi: 10.1177/1010428317715804